Find disease awareness content and relevant supporting materials
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Men with high serum prostate specific antigen usually undergo transrectal ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects including bleeding, pain, and infection...
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation.
In the UK, prostate cancer (PC) is the most common cancer in men. A diagnosis can be confirmed only following a prostate biopsy.
Prostate cancer diagnosis on repeat magnetic resonance imaging-transrectal ultrasound fusion biopsy of benign lesions: recommendations for repeat sampling.
Urologists face a dilemma when a lesion identified on multiparametric magnetic resonance imaging is benign on image guided fusion biopsy.
33rd Annual EAU Congress 2018: Major study shows prostate MRI reveals more cancers which need treatment and reduces over diagnosis compared to standard biopsy
A large international study has shown that an MRI scan can reduce the number of invasive prostate biopsies by up to 28%.